Abstract
We report the results of a study of serum antibodies to proteins of the nerve cytoskeleton in patients with Type I and Type II diabetes mellitus, both with and without clinical signs of diabetic neuropathy. In contrast to previous reports, elevated levels of antibody to tubulin or glycated tubulin were not associated with either diabetes or diabetes with related neuropathy. Similarly, clinical evidence of neuropathy in patients with diabetes did not relate to increased levels of antibody to native or glycated microtubule-associated proteins (MAPs). The levels of antibody to MAPs and glycated MAPs were higher in control subjects over the age of 45 years compared with younger control subjects. Increased levels of antibody to tubulin and glycated tubulin were found in the sera of patients with systemic lupus erythematosus, but not rheumatoid arthritis. © 1991 Humana Press.
Original language | English |
---|---|
Pages (from-to) | 159-172 |
Number of pages | 13 |
Journal | Molecular and chemical neuropathology |
Volume | 15 |
Issue number | 2 |
DOIs | |
Publication status | Published - Oct 1991 |
Keywords
- autoantibodies
- diabetes
- diabetic complications
- glycation
- microtubule-associated proteins
- Microtubules
- neuronal antibodies
- neuropathies
- rheumatoid arthritis
- SLE
- tubulin